Eye Burns: Clinical Trials

5 trials for Eye Burns, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 2 recruiting. 2 Not applicable, 2 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Recruiting 1, Unknown 1
Phase 22Unknown 2
Phase 32Unknown 2

Follow Eye Burns: new trials by email Literature Review of Eye Burns trials Research Report on Eye Burns

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
OCTA Evaluated the Efficacy of Glucocorticoid Retrobulbar Injection in Retinal Photo-injury
retrobulbar injection of glucocorticoid - Retinal Light Damage, Photic Retinopathy
RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine502026-10-092026-10-09
Vit-A-VisionĀ® Clinical Investigation
Vit-A-Vision - Burning Eye, Irritation; Eyeball
Not applicableRecruitingOmniVision GmbH772025-12-192026-01-16
Modified Corneal EA With Middle LKP for Severe Corneal Burn
Modified EA and AMLK, LA and AMLK - Corneal Burn
Not applicableUnknownSun Yat-sen University202018-05-102019-09-09
Low Dose Doxycycline in the Treatment of Corneal Burn
Doxycycline, Placebo - Eye Burns
Phase 2 / Phase 3UnknownSun Yat-sen University402013-09-012013-08-09
The Role of Amniotic Membrane Transplantation in Ocular Chemical Burns
amniotic membrane transplantation - Eye Burns
Phase 2 / Phase 3UnknownShahid Beheshti University of Medical Sciences902006-07-012008-09-25

Narrower conditions

Asthenopia (1)  ·  Dry Eye Syndromes (1)  ·  Foveomacular Retinitis (1)

Broader conditions

Craniocerebral Trauma (5)  ·  Eye Injuries (5)  ·  Facial Injuries (5)  ·  Nervous System Diseases (5)  ·  Trauma, Nervous System (5)  ·  Wounds and Injuries (5)  ·  Burns (4)  ·  Eye Diseases (2)  ·  Lacrimal Apparatus Diseases (1)  ·  Radiation Injuries (1)  ·  Retinal Diseases (1)

Interventions

Chlortetracycline (1)  ·  Doxycycline (1)  ·  sulfadiazine, tetroxoprim drug combination (1)

Sponsors

Sun Yat-sen University (2)  ·  OmniVision GmbH (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Shahid Beheshti University of Medical Sciences (1)

Countries

China (3)  ·  Germany (1)  ·  Iran (1)

Top investigators

Alireza Baradaran Raffiee, MD (1)  ·  Dan Liang, MD (1)  ·  Norbert Schrage, Prof. Dr. (1)